Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opicapone effect on levodopa pharmacokinetics in healthy subjects
NCT02170376Phase 1Completed
- Sponsor
- BIAL
- Start
- Sep 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Sep 2011; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02170376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170376.